ARQT Arcutis Biotherapeutics Inc

$ARQT I only bought this stock because after almost two decades of dealing with sebherroic dermatitis, Zorvey is the first drug that actually works!

$ARQT Nobody is talking about $ARQT. Today it ripped +10.6% to a 52-week high on 3x volume. A +59% grower. BlackRock just opened a $276M position. Here's what the institutions knows that you don't. Whale check 🐋 BofA added $78M. Jupiter and Bamco opened new stakes too. Over 100% institutionally owned. The big money is buying, not leaving. The growth is real: Q2 revenue $130M, +59% YoY. Beat on both lines. First profitable quarters just printing. FY guide raised to $525–540M. The highest grower on the list. Zoryve scripts feed the guide. The average target sits well above the stock. The fresh initiation sits way above that. Long Term: branded dermatology is expanding and Arcutis is taking share. Levels: $31–31.50 zone. Below $28.82, I'm wrong. If this thesis plays out, Q3 confirms the guide and the initiation math takes over. The trend stays up. The breakout holds. If it closes below $28.82 instead, forget everything above. Educational only. Not financial advice.

$ARQT Arcutis Biotherapeutics part of #IBD "Profitable Biotech" closed today at the highest levels in 5 yrs, exceeding base since late '25. While many sectors continue to show evidence of being under severe pressure in a way that will lead many to likely still require consolidation in Nov even on a bounce in late Oct, many parts of HC have come to life and a MUST to pay attention to this rotation.

Latest analyst update, October 19, 2026: An analyst kept its Buy rating on Arcutis and raised its price target to $44 from $38 (a third-party opinion, not a recommendation). Arcutis ($ARQT) Stock Hub: ZORYVE Revenue Grew To $129.9 Million In The Second Quarter, With Index Entry Done And The February PDUFA Ahead Not investment advice. More details in our stock hub.

$ARQT Yup yup yup.... The closer to earnings the higher the SP will get. Book it. Fucking clowns dont want to get caught shorting a winner like last time.

$ARQT The volatility with this stock is suspicious. I don’t understand why it keeps fluctuating so much down and then up on no public information. I know many people suspect shenanigans by the toots, which is possible. The fair intrinsic value is about $35 - 40 per share.

$ARQT So, explain to me why the SEC knowingly allows Market Makers to sell 141.2 million shares out of a total of 126 million issued shares and to keep their naked short position open for 10 months when the law requires any naked short position to be closed out in a maximum of 3 days?

Click the link below to join Starlight ⬇️ Easily the best small-cap community I’ve found 🔥 It’s completely free to join for now, but access is limited/8 Watchingg $ARQT $ICG ||

$ARQT The MM Mafia desperately needs sellers to cover their estimated 45+ million counterfeit share open naked short positions. (Add Imstitutional short positions of 20 million shares and the entire retail investor inventory of shares bc institutional ownership alone is 112.5% of all issued shares), because the Mafiosi only get sellers by dropping their Bid & Ask.